Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Plastic Degradation Company, Breaking, Emerges from Stealth with Naturally-Derived Solution to Degrade Multiple Plastics with $10.5M in Seed Funding
Life Sciences Times
-
April 22, 2024
0
Venture Capital
Exowatt Launches with $20 Million to Modernize Data Center Power for the AI Era
Life Sciences Times
-
April 22, 2024
0
Venture Capital
Rubedo Life Sciences Closes $40M Series A Financing Led by Khosla Ventures and Ahren Innovation Capital
Life Sciences Times
-
April 22, 2024
0
Venture Capital
PharmAlliance Announces Acquisition of CHEORS
Life Sciences Times
-
April 16, 2024
0
Venture Capital
CG Life Acquires Toolhouse, Significantly Expanding Technology-Enabled Omnichannel Capabilities
Life Sciences Times
-
April 9, 2024
0
Venture Capital
Inrad Optics To Be Acquired by Luxium Solutions for $19 Million
Life Sciences Times
-
April 9, 2024
0
People on the Move
PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions
Life Sciences Times
-
April 9, 2024
0
Venture Capital
Neurosterix launches with $63M to Advance Allosteric Modulator Therapeutics for Neurological Disorders
Life Sciences Times
-
April 3, 2024
0
Venture Capital
Alterome Therapeutics Raises $132 Million in Series B Financing Led by Goldman Sachs Alternatives
Life Sciences Times
-
April 3, 2024
0
Venture Capital
Conformation-X Therapeutics Bolts out of Stealth, Securing Over $13.5M in Funding to Propel Its Innovative Immune-Oncology Pipeline
Life Sciences Times
-
April 3, 2024
0
Venture Capital
Miach Orthopaedics Raises $20 Million in Series B Extension
Life Sciences Times
-
April 2, 2024
0
Venture Capital
H.I.G. Capital Acquires the Spine Business of ZimVie Rebranded as Highridge Medical
Life Sciences Times
-
April 1, 2024
0
1
...
32
33
34
...
115
Page 33 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026